Skip to main content
Clinical Trials/NCT00180908
NCT00180908CompletedPhase 3

SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma

Gustave Roussy, Cancer Campus, Grand Paris2 sites in 1 country226 target enrollmentStarted: June 1994Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
226
Locations
2
Primary Endpoint
Good histological response (5% or less viable cells) after preoperative chemotherapy

Study Overview

Brief Summary

The purpose of this study is to compare two preoperative chemotherapy regimens based on high-dose methotrexate courses given alternately either with doxorubicin or with etoposide-ifosfamide.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
— to 20 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • non metastatic limb osteosarcoma,
  • age less than 20 years,
  • biopsy proven high-grade osteosarcoma,
  • no previous treatment,
  • no contraindication to chemotherapy
  • no previous malignancy,
  • Written informed consent.

Exclusion Criteria

  • juxta-cortical sarcoma and microcellular anaplastic sarcoma,
  • previous anticancer treatment
  • contraindication to chemotherapy
  • previous malignancy,

Outcomes

Primary Outcomes

Good histological response (5% or less viable cells) after preoperative chemotherapy

Secondary Outcomes

  • Event-free survival,
  • Overall survival,
  • Toxicity.

Investigators

Study Sites (2)

Loading locations...

Similar Trials